Syndax Pharmaceuticals (SNDX) EBITDA Margin Growth (3y) (2018 - 2024)
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) EBITDA Margin Growth (3y) (2018 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -2,649.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 30,461.00 |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.28 Bn | 60.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -133,040.00 |
| Sep 30, 2024 | -55,474.00 |
| Jun 30, 2024 | 377,242.00 |
| Dec 31, 2021 | 516,328.00 |
| Sep 30, 2021 | 454,551.00 |
| Jun 30, 2021 | -89,261.00 |
| Mar 31, 2021 | -195,567.00 |
| Dec 31, 2020 | -359,270.00 |
| Sep 30, 2020 | -17,400.00 |
| Jun 30, 2020 | 15,577.00 |
| Mar 31, 2020 | 33,616.00 |
| Dec 31, 2019 | -8,537.00 |
| Sep 30, 2019 | 152,667.00 |
| Jun 30, 2019 | -122,564.00 |
| Mar 31, 2019 | -103,808.00 |
| Dec 31, 2018 | -355,353.00 |
| Sep 30, 2018 | -278,673.00 |
| Jun 30, 2018 | 2.76 Mn |